Our Nomogram can calculate the likelihood of ypN0 response in patients undergoing neoadjuvant chemotherapy with cT1-3 and cN1-2 disease. Table No. 3 describes more in-depth the score for each variable. Higher scores indicate a greater likelihood of negative nodes on final pathology, suggesting that axillary de-escalation strategies (e.g., sentinel lymph node biopsy/targeted axillary dissection) may be effective.

 

Select the option that most resembles your patient's information in each section.

 

Our Nomogram is a predictive tool; thus, it should not be used as a definitive diagnosis.